In severe cases, dehydration or hypoglycemia (especially if used with certain drugs like insulin or sulfonylureas) can occur
Regulatory and safety status: It is currently awaiting FDA review
Retatrutide's triple receptor agonism offers complementary metabolic effects through simultaneous GLP-1, GIP, and GCG pathway activation, studied for synergistic metabolic regulation, glucose homeostasis, and weight management research.nnMechanisms: Enhanced insulin secretion, improved glucose utilization, reduced appetite signaling, increased energy expenditure, and metabolic adaptation through three hormone pathways.nnProduct Specifications: GLP-3RT Retatrutide 10mg lyophilized | 99% purity HPLC verified | Storage -20C lyophilized, 2-8C reconstituted | COA includednnResearch applications: Metabolic disease modeling, dose-response studies, glucose control pathways, weight regulation mechanisms, multi-receptor GLP/GIP/GCG activation, and metabolic syndrome reversal investigation
Cavallini G
For Real-Time PCR amplification, the Maxima SYBR Green qPCR Master Mix was used, with primers designed for the target genes StAR (Steroidogenic Acute Regulatory Protein), 3-HSD (3-Hydroxysteroid Dehydrogenase), Cyp17a (Cytochrome P450 17A1), Aromatase and GAPDH as an internal control